Soleno Therapeutics (SLNO) Liabilities from Discontinued Operations (2016 - 2018)

Soleno Therapeutics (SLNO) has 3 years of Liabilities from Discontinued Operations data on file, last reported at 110000.0 in Q3 2018.

• On a quarterly basis, Liabilities from Discontinued Operations fell 2.65% year-over-year to 110000.0 in Q3 2018; TTM through Sep 2018 was 110000.0, a 2.65% decrease from a year earlier, with the FY2017 full-year figure at 225000.0, down 8.69% from the prior year.
• Liabilities from Discontinued Operations for Q3 2018 stood at 110000.0, down from 1050000.0 in the prior quarter.
• Over the last five years, Liabilities from Discontinued Operations for SLNO reached as high as 1050000.0 in Q2 2018 and fell as low as 110000.0 in Q3 2018.
• Historically, Liabilities from Discontinued Operations has averaged 369057.14 across 3 years, with a median of 225000.0 in 2017.
• Across the five-year window, Liabilities from Discontinued Operations dropped 8.69% in 2017 and soared 390.65% in 2018, its largest moves.
• Year by year, Liabilities from Discontinued Operations stood at 246400.0 in 2016, then fell by 8.69% to 225000.0 in 2017, then sank by 51.11% to 110000.0 in 2018.
• Per Business Quant data, the three most recent Liabilities from Discontinued Operations figures were 110000.0 in Q3 2018, 1050000.0 in Q2 2018, and 625000.0 in Q1 2018.